Cervical cancer is the 2nd most common cancer in women worldwide and the leading cause of cancer deaths in women in developing countries. 80 % of the 400,000 worldwide cervical cancer cases diagnosed yearly are in developing countries, where most women who die from this disease are in their 30s and 40s. Although cervical cancer has become rare in the US, due to decades of Pap smear screening and treatment of pre-cancers, in developing countries there are still over 1.7 million cases of cervical cancer and 5-13 million cases of pre-cancer. In 2007, the Cameroon Baptist Cameroon Health Board (CBCHB) began a partnership with the University of Alabama’s Cervical Health Program in Zambia University Teaching Hospital. The program pioneers a new method of cervical cancer screening, using digital photo-cervicography instead of Pap smears (which are neither available nor affordable for most African women). Although no funds are available for a similar program in Cameroon, the Zambian program has provided training both on site and in Zambia for CBCHB staff given that it is the first African transcontinental internet consultation service for difficult cases. The CBCHB also works in collaboration with the Cameroonian National Fight Against Cancer in program planning and patient referral. The CBCHB Cervical Cancer and Women's Health Program has now launched a mobile cervical cancer screening clinic, using a US-donated military ambulance. The mobile van would travel to various clinics and support group meetings to screen women of cervical cancer, with priority given to HIV-positive women, since they are at highest risk. The Board is developing expertise in cryotherapy and the loop electrical excision procedure (LEEP) to treat pre-cancers. It also plans to train experts in radical surgery techniques and cancer staging.